StockData

Black Hawk Acquisition Corp (BKHA) company profile

BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 5/30
$8.61−0.04 (-0.46%)

Close on Nov 18, 2026Market cap $35.76MP/E –Yield –

About Black Hawk Acquisition

Biological Products, (No Diagnostic Substances), SIC 2836

The company is a blank check entity established to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more operational businesses. It does not sell commercial products, manufacture goods, or provide traditional commercial services, and it does not serve standard retail or enterprise consumers. Instead, its sole operational endeavor consists of identifying, conducting due diligence on, and evaluating suitable acquisition target candidates seeking access to public capital markets, including pursuing a definitive business combination agreement with a therapeutics enterprise.

Incorporated as an exempted company with limited liability in the Cayman Islands, the organization maintains an international deal-sourcing scope without geographic restrictions on potential targets. Its management team operates from the United States with extensive networks spanning North America and global markets, though the filing does not report physical storefronts, operational facilities, or a specific corporate headquarters address.

Summary of the business section of Black Hawk Acquisition's latest annual report, written by StockData.

Company profile

Company

Legal name
Black Hawk Acquisition Corp
Founded
2023
Headquarters
Danville, CA
Address
4125 Blackhawk Plaza Circle, Suite 166 94506
Phone
(203) 520-7122
Employees
10, Nov 30, 2025
Industry
Biological Products, (No Diagnostic Substances)
Fiscal year ends
November 30
Auditor
MaloneBailey, LLP, Houston, Texas

Stock & identifiers

Ticker
BKHA
Other tickers
BKHAR, BKHAU
Exchange
Nasdaq
IPO date
Mar 22, 2024
Shares outstanding
4M, Oct 6, 2026
Public float
$73.90M, May 31, 2025
Filer category
<br>Emerging growth company
SEC CIK
2000775
FIGI
BBG01M9PC9K0
Share class FIGI
BBG01M9PCB43
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Black Hawk Acquisition's leadership is listed in its proxy statement, last filed Jun 10, 2025.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Mar 22, 2024
Securities offered
6,900,000
Exchange
Nasdaq
First trading day
Mar 21, 2024
First-day close
$10.15
Lock-up ends (est.)
Sep 17, 2024

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“● our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; … ● the other risk and uncertainties discussed in “Item 1A. Risk Factors,” elsewhere in this Annual Report on Form 10-K and in our other filings with the SEC.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?